Operational information

This data is publicly available. Parent page : ION-8139

Operational data for Matchis Foundation - ION-8139

Organisation Overview
The information has been reviewed in year :
Issuing organisation Number (ION)ION-8139
The Issuing Organisation Number of a organisation, this is globally unique number, as issued by the ICCBBA.
Time zoneEurope/Amsterdam (GMT+01:00)
The timezone in which this organisation operates.
Business hours8:30 - 17:30
The daily hours in which this organisation operates.
Work scheduleMON-FRI
The normal work week in which this organisation operates.
Organisation closures
For all organisation closures, please see the WMDA Calendar.
Donor ID exampleNLxxxxxxxx or NLxxxxxxxD or 8139 xxxx xxxx xxxx xxx
ID to be expected on paperwork, samples, and products.
Preliminary Search
Requires preliminary search request formNo
If yes, form required can be found on the Documents Page.
Extended Typing
Typing options available for requestHR,LR,IR, A,B,C,DR,DP,DQ,DRB1
Please note special requirements listed
Requires organisation specific typing request formNo
If yes, form required can be found on the Documents Page.
Number of days donor is reserved for a patient after a request90 days
Verification Typing
Maximum blood volume allowed100
Requires organisation specific typing request formNo
If yes, form required can be found on the Documents Page.
IDM testing performed at verificationYes
Number of days donor is reserved for a patient after a request2 weeks
Sibling Typing
Registry is willing to arrange sibling typingsYes
If yes, procedure to apply for sibling typings By email request; then we will ask you to complete WMDA forms (they will be sent to you)
Workup Request
Product dosage limitdepends on donor
Number of donor cells allowed based on recipient weight.
Requires patient to meet certain standards in order to proceed with collectionYes
Organisation may or may not allow donor collections for some patients.
Patient physician must report the following in order to proceed with collectionSee minimal criteria document
Must provide additional information to organisation.
Requires organisation specific work up forms No
If yes, form(s) required can be found on the Documents Page.
Workup IDM completed 30 days prior to collectionYes
Donor IDM results must be performed within 30 days of collection date to be valid and allow the collection to proceed.
Medical Health Questionnaire example availableYes
If yes, the example can be found on the Documents Page.
Post-Transplant
Subsequent donation policyAllowed, under supervision of Medical Advisory Board
Anonymous contact allowedAnonymous postcards or letters
Direct contact allowedNO
Gift exchange allowedYES, small presents and not valuable
Cord blood contact allowedN.A.

IDM

IDM TestedMethod Days between test
and sampling/workup
ALT/ASTALT/AST ratio, De-Ritis-Quotient Yes
ChagasChagas, T. cruzi On request
CMV IgGCytomegalovirus (CMV) Antibody testing IgG YesChemiluminescence Immunosorbent (CLIA) - Architect
CMV IgMCytomegalovirus (CMV) Antibody testing IgM On requestChemiluminescence Immunosorbent (CLIA) - Architect
CMV TotalCytomegalovirus Total On request
EBV IgGEpstein-Barr Virus Antibody testing IgG On requestChemiluminescence Immunosorbent (CLIA) - Liaison
EBV IgMEpstein-Barr Virus Antibody testing IgM On requestChemiluminescence Immunosorbent (CLIA) - Liaison
HAV (NAT)Anti-hepatitis A virus nucleic acid testing -
HBV (NAT)Hepatitis B nucleic acid testing YesQuantitative RT-PCR
HBc AbHepatitis B core antibody testing YesChemiluminescence Immunosorbent (CLIA)
HBs AgHepatitis B Surface antigen testing YesChemiluminescence Immunosorbent (CLIA) - Architect
HCV (NAT)Hepatitis C nucleic acid testing YesQuantitative RT-PCR - Cobas Taqman
HCV AbHepatitis C antibody testing YesChemiluminescence Immunosorbent (CLIA)
HEV (NAT)Hepatitis E Virus nucleic acid testing -Qualitative RT-PCR
HIV (NAT)Human Immunodeficiency Virus nucleic acid testing YesQuantitative RT-PCR
HIV-1 AbHuman Immunodeficiency Virus HIV-1 antibody testing YesChemiluminescence Immunosorbent (CLIA) - Architect - HIV score blot
HIV-2 AbHuman Immunodeficiency Virus HIV-2 antibody testing YesChemiluminescence Immunosorbent (CLIA) - Architect - HIV score blot
HIV p24Human Immunodeficiency Virus p24 antigen testing On requestChemiluminescence Immunosorbent (CLIA) - Architect - HIV score blot - HIV duo ultra (VIDAS)
HTLV-IHuman T-Lymphotropic Virus type I testing YesChemiluminescence Immunosorbent (CLIA) - Architect - Immunoblot
HTLV-IIHuman T-Lymphotropic Virus type II testing YesChemiluminescence Immunosorbent (CLIA) - Architect - Immunoblot
MalariaMalaria -serology or PCR
HSVHerpes Simplex Virus -serology or PCR - Diasorin Liaison XL HSV IgG
STSSerological tests for syphilis YesChemiluminescence Immunosorbent (CLIA) - TP Architect - lues blot (INNO-LIA innogenetics ) RPR titratie
STS FTA-ABSSerological test for syphilis On requestonly at positive STS serology - TP Architect - lues blot Fujiredio
ToxoplasmosisToxoplasmosis -Chemiluminescence Immunosorbent (CLIA)
VZVVaricella Zoster Virus -Chemiluminescence Immunosorbent (CLIA) - Diasorin Liaison XL VZV IgG
WNV-NATWest Nile Virus nucleic acid testing On request
Other tests performed No

Regulatory information

The data provided on this page is updated by the organisations.
The WMDA makes no representations or express or implied warranties regarding any information on this page.
Use of any information provided on this site does not and is not intended to create a contractual or other relationship.

General

The information has been reviewed in year :2024
Organisation name:Matchis Foundation
Organisation ION:ION-8139
Country:The Netherlands
Year the registry started operations:1988

Products

comment
Do you provide HPC, Marrow? yes
Do you provide HPC, Apheresis? yes
Do you provide HPC, Cord Blood? no Requests for Dutch CBU is forwarded to Sanquin ION-1131
Do you provide MNC, Apheresis? yes
Do you provide NC, Whole Blood? no

Product quantity

Data valid for year2023
Number of products NationalInternational
HPC, Marrow products: 9 19
HPC, Apheresis: 28 209
HPC, Cord: 0 0

License

Organisation is licensed/accredited by the Competent Authority: yes
Comment:Tissue establishment license
Name of Competent Authority:Ministry of Health, Welfare, Sport; Inspected by IGJ
Date of last inspection:2024/01
Link to website of Competent Authority:https://www.government.nl/ministries/ministry-of-health-welfare-and-sport
Can you provide the Legal documentation from the Competent Authority that your organisation is allowed to operate as a registry ? yes
Is your registry WMDA Certified, WMDA Qualified or WMDA Accredited?WMDA Accredited
The registry is accredited by any other organisation: yes
If yes, by which organisation?ISO27001/NEN7510 certification - data protection

Affiliation

The registry works with the following number of affiliated donor centres:0 (Donor centre is a department of the Registry (operating in Leiden and Nijmegen)
The registry audits its donor centres:yes, internal audits
The registry works with the following numer of affiliated collection centres:2
Ther registry audits its collection centres:yes
The registry works with the following number of affiliated Cord Blood Banks:no
The registry audits its Cord Blood Banks:no
The registry works with the following number of affiliated transplant centres:10
The registry audits its transplant centres:no, Transplant centers in the Netherlands are JACIE accredited. Compliance statements to WMDA standards are required
The registry works with the following number of affiliated IDM Testing Laboratories:3
The registry audits its IDM Testing Laboratories:no
The registry works with the following number of affiliated HLA/other DNA markers testing laboratories:3
The registry audits its HLA/other DNA markers testing laboratories:not standard procedure
The registry would be able to provide a full list of name/addresses of each affiliated and their licence/accreditation status, on request: yes
The Cord Blood Banks are FACT-NetCord accredited:
If yes, the following Cord Blood Bank(s) are accredited:
The registry is able to provide a copy of all the certificates: yes
Affiliated centres comply with WMDA Standards and applicable national regulations: yes
The registry has requirements for affiliated centres in addition to WMDA Standards and applicable national regulations: yes
If yes, what are these requirements?For the national Transplant centers: License for transplantation with unrelated HPC donor and JACIE accreditation

Donor policy

All donors are unpaid volunteers: yes
All donors are informed about donation process and associated risks: yes
Donors sign a valid informed consent to donate in the presence of a medical doctor/health care personnel/registry staff: yes
The registry has systems in place to protect and control access to donor/patient records: yes
The registry maintains donor anonymity: yes
The registry has detailed donor evaluation and exclusion criteria in place: yes
The registry has donor evaluation and exclusion criteria that do meet or exceed the WMDA guidelines:


Testing

The physical and medical exam at donor workup is performed by a medical doctor: yes
All donor testing (at workup) for infectious disease is performed in a laboratory certified/licensed by a Competent Authority: yes
HLA typing for patient specific request is performed in an appropriately accredited laboratory: yes
Sterility testing is performed on the adult donor product: yes
Sterility testing is performed on the cord blood product:
Screening questionnaire to exclude communicable disease: yes
Screening questionnaire to exclude donors with 'high risk' lifestyles: yes
Donor reliability identified by a medical doctor: yes
Donor clearance to donate is confirmed by a medical doctor, following as a minimum the donor exclusion criteria in Annex 1 of EU Directive 2006/17/EC :

The party providing the cell product must exclude donors when:

  • They are pregnant;
  • They are breastfeeding;
  • There is the potential for transmission of inherited conditions;
  • There is evidence of any other risk factors for transmissible diseases on the basis of a risk assessment, taking into consideration Donor travel and exposure history and local infectious disease prevalence;
  • There is presence on the donor’s body of physical signs implying a risk of transmissible disease(s);
  • There is a history of a disease of unknown aetiology;
  • There is a risk of transmission of diseases caused by prions;
  • There is systemic infection which is not controlled at the time of donation, including bacterial diseases, systemic viral, fungal or parasitic infections, or significant local infection in the tissues and cells to be donated;
  • There is history of chronic, systemic autoimmune disease that could have a detrimental effect on the quality of the Cell Product;
  • There is recent history of vaccination with a live attenuated virus where a risk of transmission is considered to exist;
  • There is ingestion of, or exposure to, a substance (such as cyanide, lead, mercury, gold) that may be transmitted to recipients in a dose that could endanger their health.
 yes

Customs regulations

Are there any customs regulations to follow, or customs paperwork required, to import cell products into the organisation country? If yes, please specify:No specific custom regulation for import cells out of the Netherlands
Are there any customs regulations to follow, or customs paperwork required, to export cell products from the organisation country? If yes, please specify:Standard procedure for export: Prior to shipment notification to customs and security; to accompany the product: Collection report, collection details, Transport Audit form, Transplant report, confidentiality policy, if for NMDP: IDM's, declaration of donor eligibility
Are there any import regulations to follow, or paperwork required, to import cell products into the organisation country? If yes, please specify:Matchis is licensed to import HPC into the Netherlands and follows strict Matchis safety policies
Are there any export regulations to follow, or paperwork required, to export cell products from the organisation country? If yes, please specify:

Reporting of Serious Adverse Events

Please indicate which of the following schemes for reporting Serious Adverse Events relating to either the Donor or the product the Registry participates in:
- Mandatory National Reporting Scheme yes
- Voluntary National Reporting Scheme
- WMDA SEAR/SPEAR Reporting Scheme yes
The registry will notify the receiving Registry within 24 hours of receiving information relating to any serious adverse event that could be considered to affect the patient receiving the product: yes

Quality management

The registry does maintain Standard Operating Procedures for your work: yes
The registry would be willing to provide these to WMDA or another registry upon request: yes
The registry would be willing to provide WMDA or another registry, on request, with copies of any packaging the HPC product will arrive in: yes
Donor records relating to the medical exam and HPC collection process are the following number(s) of year(s) retained:30

  • No labels